CDK Global to Announce Third Quarter Fiscal 2016 Financial Results on May 5, 2016
Mar 28, 2016 20:05 pm UTC| Business
HOFFMAN ESTATES, Ill., March 28, 2016 -- CDK Global, Inc. (Nasdaq:CDK) is scheduled to release its financial results for the fiscal third quarter ending March 31, 2016 before the opening of the Nasdaq on Thursday, May...
Gaming and Leisure Properties, Inc. Announces Public Offering of 19,000,000 Shares of Common Stock
Mar 28, 2016 20:05 pm UTC| Business
WYOMISSING, Pa., March 28, 2016 -- Gaming and Leisure Properties, Inc. (the “Company” or “GLPI”) (NASDAQ:GLPI), the first publicly traded gaming-focused REIT in North America, today announced that it has commenced an...
Nanometrics Achieves Record 3D-NAND Bookings Quarter
Mar 28, 2016 20:05 pm UTC| Business
MILPITAS, Calif., March 28, 2016 -- Nanometrics Incorporated (NASDAQ:NANO), a leading provider of advanced process control systems, today announced record 3D-NAND bookings totaling over $38 million for the first quarter...
The Children’s Place Appoints John E. Bachman to Its Board of Directors
Mar 28, 2016 20:05 pm UTC| Business
SECAUCUS, N.J., March 28, 2016 -- The Children’s Place, Inc. (Nasdaq:PLCE), the largest pure-play children’s specialty apparel retailer in North America, today announced it has appointed John E. (“Jeb”) Bachman to the...
HomeTrust Bancshares Announces Appointment of Three New Directors
Mar 28, 2016 20:05 pm UTC| Business
ASHEVILLE, N.C., March 28, 2016 -- HomeTrust Bancshares, Inc. (the “Company”) (NASDAQ:HTBI), the holding company for HomeTrust Bank (the “Bank”), announced today that the Company’s Board of Directors (the “Board”) has...
Atara Bio Announces Participation in Two Upcoming Immuno-Oncology Conferences
Mar 28, 2016 20:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 28, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Mar 28, 2016 20:05 pm UTC| Business
MALVERN, Pa., March 28, 2016 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical stage specialty pharmaceutical company, today announced that it has entered into an agreement with the stockholders of Vixen...